Publication | Closed Access

Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction

HypertensionHeart FailureCardiovascular DiseaseMedicinePhysiologyEndothelial DysfunctionCardiovascular PharmacologyEndothelial Vasomotor DysfunctionVascular BiologyPharmacotherapyCardiovascular FunctionPharmacologyCardiologyAngiotensin-converting Enzyme Inhibition